Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

Saved in:

Bibliographic Details
Published in:	Leukemia Vol. 27; no. 10; pp. 2102 - 2105
Main Authors:	Zimmermann, H, Choquet, S, Moore, J, Salles, G, Morschhauser, F, Lamy, T, Jaccard, A, Horst, H A, Leithäuser, M, Dührsen, U, Reinke, P, Lebranchu, Y, Neuhaus, R, Lehmkuhl, H, Tarella, C, Schlattmann, P, Riess, H, Leblond, V, Trappe, R U
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-10-2013 Nature Publishing Group Springer Nature
Subjects:	692/308/2779/109 692/699/249/1623 692/699/67/1059 692/700/1750 Antigens, CD20 Antigens, CD20 - metabolism Blood Cell Count Blood tests Cancer Research CD20 antigen Chemotherapy Complications and side effects Critical Care Medicine Dosage and administration Drug therapy Follow-Up Studies Hematology Humans Immunology Immunosuppressive agents Intensive Internal Medicine letter-to-the-editor Letters to the editor Leukemia Life Sciences Lymphocytes Lymphoma Lymphomas Lymphoproliferative Disorders Lymphoproliferative Disorders - blood Lymphoproliferative Disorders - diagnosis Lymphoproliferative Disorders - etiology Lymphoproliferative Disorders - mortality Medical prognosis Medicine Medicine & Public Health Mutation Neutrophils Oncology Organ Transplantation Organ Transplantation - adverse effects Postoperative Complications Posttransplant lymphoproliferative disorders Prognosis Prospective Studies Retrospective Studies Survival Rate Transplants & implants France Germany
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Correspondence-1
ISSN:	0887-6924 1476-5551
DOI:	10.1038/leu.2013.110